LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-edge Cancer Therapeutics NuCana plc is at the forefront of developing advanced cancer therapies through their innovative ProTide technology, offering a unique selling point for healthcare providers seeking more effective and safer treatment options for cancer patients.

Strategic Research Collaborations Partnerships like the one with Worcester College and Oxford University demonstrate NuCana's commitment to collaborating with academic institutions, which can be leveraged as an entry point for sales discussions with universities, research centers, and potential investors.

Renowned Medical Professionals on Board The addition of experienced leaders like Dr. Elliott M. Levy and Dr. Jeffrey D. Bloss to NuCana's team enhances the company's credibility and expertise in the field of oncology, presenting opportunities for sales engagements with key opinion leaders and medical institutions.

Expansion of Clinical Program NuCana's recent updates on their broad clinical program with transformative ProTide therapeutics indicate growth and progress, opening doors for sales pitches targeting healthcare professionals, pharmaceutical companies, and investors interested in cutting-edge oncology treatments.

Innovative Leadership in Biotech With Andrew Kay leading as Chairman and driving significant improvements in cancer treatment outcomes, NuCana presents a compelling narrative for sales representatives to approach investors, healthcare organizations, and governmental bodies seeking to support groundbreaking biotechnological advancements.

Similar companies to NuCana plc

NuCana plc Tech Stack

NuCana plc uses 8 technology products and services including Google Analytics, Unpkg, Cookiebot, and more. Explore NuCana plc's tech stack below.

  • Google Analytics
    Analytics
  • Unpkg
    Content Delivery Network
  • Cookiebot
    Cookie Compliance
  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • AOS
    Javascript Libraries
  • Prefix-Free
    Miscellaneous
  • Google Tag Manager
    Tag Management

Media & News

NuCana plc's Email Address Formats

NuCana plc uses at least 1 format(s):
NuCana plc Email FormatsExamplePercentage
FirstLast@nucana.comJohnDoe@nucana.com
48%
FirLast@nucana.comJohDoe@nucana.com
2%
FirstLast@nucana.comJohnDoe@nucana.com
48%
FirLast@nucana.comJohDoe@nucana.com
2%

Frequently Asked Questions

Where is NuCana plc's headquarters located?

Minus sign iconPlus sign icon
NuCana plc's main headquarters is located at 3 Lochside Way Edinburgh, Scotland EH12 9 GB. The company has employees across 2 continents, including EuropeNorth America.

What is NuCana plc's phone number?

Minus sign iconPlus sign icon
You can contact NuCana plc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NuCana plc's stock symbol?

Minus sign iconPlus sign icon
NuCana plc is a publicly traded company; the company's stock symbol is NCNA.

What is NuCana plc's official website and social media links?

Minus sign iconPlus sign icon
NuCana plc's official website is nucana.com and has social profiles on LinkedIn.

How much revenue does NuCana plc generate?

Minus sign iconPlus sign icon
As of September 2024, NuCana plc's annual revenue reached $3.8M.

What is NuCana plc's SIC code NAICS code?

Minus sign iconPlus sign icon
NuCana plc's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NuCana plc have currently?

Minus sign iconPlus sign icon
As of September 2024, NuCana plc has approximately 38 employees across 2 continents, including EuropeNorth America. Key team members include Chief Financial Officer: D. M.Vice President Project Management: B. D.Head Of Translational Medicine: D. H.. Explore NuCana plc's employee directory with LeadIQ.

What industry does NuCana plc belong to?

Minus sign iconPlus sign icon
NuCana plc operates in the Biotechnology Research industry.

What technology does NuCana plc use?

Minus sign iconPlus sign icon
NuCana plc's tech stack includes Google AnalyticsUnpkgCookiebotGoogle Font APIFont AwesomeAOSPrefix-FreeGoogle Tag Manager.

What is NuCana plc's email format?

Minus sign iconPlus sign icon
NuCana plc's email format typically follows the pattern of . Find more NuCana plc email formats with LeadIQ.

When was NuCana plc founded?

Minus sign iconPlus sign icon
NuCana plc was founded in 2008.
NuCana plc

NuCana plc

Biotechnology ResearchScotland, United Kingdom11-50 Employees

NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.

While these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilising our proprietary ProTide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. 

Section iconCompany Overview

Headquarters
3 Lochside Way Edinburgh, Scotland EH12 9 GB
Phone number
Website
nucana.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NCNA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
11-50

Section iconFunding & Financials

  • $10M

    NuCana plc's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    NuCana plc's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.